nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—kidney cancer	0.297	1	CbGaD
Silodosin—ABCB1—Temsirolimus—kidney cancer	0.0676	0.134	CbGbCtD
Silodosin—CYP3A4—Everolimus—kidney cancer	0.0599	0.119	CbGbCtD
Silodosin—CYP3A4—Temsirolimus—kidney cancer	0.0405	0.0802	CbGbCtD
Silodosin—ABCB1—Pazopanib—kidney cancer	0.0355	0.0704	CbGbCtD
Silodosin—ABCB1—Dactinomycin—kidney cancer	0.0325	0.0643	CbGbCtD
Silodosin—ABCB1—Gemcitabine—kidney cancer	0.0257	0.0509	CbGbCtD
Silodosin—ABCB1—Erlotinib—kidney cancer	0.0253	0.0502	CbGbCtD
Silodosin—ABCB1—Paclitaxel—kidney cancer	0.0232	0.046	CbGbCtD
Silodosin—CYP3A4—Pazopanib—kidney cancer	0.0213	0.0422	CbGbCtD
Silodosin—ABCB1—Sorafenib—kidney cancer	0.0206	0.0408	CbGbCtD
Silodosin—ABCB1—Vinblastine—kidney cancer	0.0203	0.0403	CbGbCtD
Silodosin—ABCB1—Vincristine—kidney cancer	0.02	0.0396	CbGbCtD
Silodosin—ABCB1—Sunitinib—kidney cancer	0.0167	0.0331	CbGbCtD
Silodosin—CYP3A4—Erlotinib—kidney cancer	0.0152	0.0301	CbGbCtD
Silodosin—CYP3A4—Paclitaxel—kidney cancer	0.0139	0.0275	CbGbCtD
Silodosin—ABCB1—Doxorubicin—kidney cancer	0.0125	0.0248	CbGbCtD
Silodosin—CYP3A4—Sorafenib—kidney cancer	0.0123	0.0245	CbGbCtD
Silodosin—CYP3A4—Vinblastine—kidney cancer	0.0122	0.0242	CbGbCtD
Silodosin—CYP3A4—Vincristine—kidney cancer	0.012	0.0237	CbGbCtD
Silodosin—CYP3A4—Sunitinib—kidney cancer	0.01	0.0198	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—kidney cancer	0.00749	0.0148	CbGbCtD
Silodosin—Mediastinal disorder—Sunitinib—kidney cancer	0.000569	0.00366	CcSEcCtD
Silodosin—Liver function test abnormal—Paclitaxel—kidney cancer	0.000566	0.00364	CcSEcCtD
Silodosin—Vascular purpura—Capecitabine—kidney cancer	0.000562	0.00362	CcSEcCtD
Silodosin—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00056	0.0036	CcSEcCtD
Silodosin—Loss of consciousness—Erlotinib—kidney cancer	0.000558	0.00359	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000556	0.00358	CcSEcCtD
Silodosin—Gastrointestinal pain—Pazopanib—kidney cancer	0.000556	0.00358	CcSEcCtD
Silodosin—Breast disorder—Paclitaxel—kidney cancer	0.000554	0.00357	CcSEcCtD
Silodosin—Mental disorder—Sunitinib—kidney cancer	0.000553	0.00356	CcSEcCtD
Silodosin—Nasopharyngitis—Paclitaxel—kidney cancer	0.000548	0.00353	CcSEcCtD
Silodosin—Dry mouth—Everolimus—kidney cancer	0.000547	0.00353	CcSEcCtD
Silodosin—Libido decreased—Capecitabine—kidney cancer	0.000542	0.00349	CcSEcCtD
Silodosin—Abdominal pain—Pazopanib—kidney cancer	0.000537	0.00346	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000536	0.00346	CcSEcCtD
Silodosin—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000533	0.00344	CcSEcCtD
Silodosin—Shock—Everolimus—kidney cancer	0.000528	0.0034	CcSEcCtD
Silodosin—Nervous system disorder—Everolimus—kidney cancer	0.000526	0.00339	CcSEcCtD
Silodosin—Tachycardia—Everolimus—kidney cancer	0.000524	0.00337	CcSEcCtD
Silodosin—Purpura—Capecitabine—kidney cancer	0.000522	0.00336	CcSEcCtD
Silodosin—Skin disorder—Everolimus—kidney cancer	0.000521	0.00336	CcSEcCtD
Silodosin—Asthenia—Temsirolimus—kidney cancer	0.000518	0.00333	CcSEcCtD
Silodosin—Syncope—Sorafenib—kidney cancer	0.000512	0.0033	CcSEcCtD
Silodosin—Pruritus—Temsirolimus—kidney cancer	0.00051	0.00329	CcSEcCtD
Silodosin—Shock—Erlotinib—kidney cancer	0.000509	0.00328	CcSEcCtD
Silodosin—Nervous system disorder—Erlotinib—kidney cancer	0.000508	0.00327	CcSEcCtD
Silodosin—Skin disorder—Erlotinib—kidney cancer	0.000503	0.00324	CcSEcCtD
Silodosin—Loss of consciousness—Sorafenib—kidney cancer	0.000502	0.00323	CcSEcCtD
Silodosin—Hypotension—Everolimus—kidney cancer	0.000501	0.00323	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.000499	0.00321	CcSEcCtD
Silodosin—Cardiac disorder—Vincristine—kidney cancer	0.000495	0.00319	CcSEcCtD
Silodosin—Diarrhoea—Temsirolimus—kidney cancer	0.000494	0.00318	CcSEcCtD
Silodosin—Asthenia—Pazopanib—kidney cancer	0.000488	0.00314	CcSEcCtD
Silodosin—Insomnia—Everolimus—kidney cancer	0.000485	0.00313	CcSEcCtD
Silodosin—Angiopathy—Vincristine—kidney cancer	0.000484	0.00312	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000483	0.00311	CcSEcCtD
Silodosin—Mediastinal disorder—Vincristine—kidney cancer	0.000481	0.0031	CcSEcCtD
Silodosin—Pruritus—Pazopanib—kidney cancer	0.000481	0.0031	CcSEcCtD
Silodosin—Dizziness—Temsirolimus—kidney cancer	0.000477	0.00307	CcSEcCtD
Silodosin—Dry mouth—Sorafenib—kidney cancer	0.000475	0.00306	CcSEcCtD
Silodosin—Cardiac disorder—Gemcitabine—kidney cancer	0.00047	0.00303	CcSEcCtD
Silodosin—Insomnia—Erlotinib—kidney cancer	0.000468	0.00302	CcSEcCtD
Silodosin—Mental disorder—Vincristine—kidney cancer	0.000468	0.00301	CcSEcCtD
Silodosin—Diarrhoea—Pazopanib—kidney cancer	0.000465	0.003	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000464	0.00299	CcSEcCtD
Silodosin—Liver function test abnormal—Capecitabine—kidney cancer	0.000464	0.00299	CcSEcCtD
Silodosin—Gastrointestinal disorder—Everolimus—kidney cancer	0.000463	0.00298	CcSEcCtD
Silodosin—Angiopathy—Gemcitabine—kidney cancer	0.000459	0.00296	CcSEcCtD
Silodosin—Orthostatic hypotension—Capecitabine—kidney cancer	0.000459	0.00296	CcSEcCtD
Silodosin—Shock—Sorafenib—kidney cancer	0.000458	0.00295	CcSEcCtD
Silodosin—Dry mouth—Sunitinib—kidney cancer	0.000457	0.00295	CcSEcCtD
Silodosin—Immune system disorder—Gemcitabine—kidney cancer	0.000457	0.00295	CcSEcCtD
Silodosin—Nervous system disorder—Sorafenib—kidney cancer	0.000457	0.00294	CcSEcCtD
Silodosin—Mediastinal disorder—Gemcitabine—kidney cancer	0.000456	0.00294	CcSEcCtD
Silodosin—Rash—Temsirolimus—kidney cancer	0.000455	0.00293	CcSEcCtD
Silodosin—Dermatitis—Temsirolimus—kidney cancer	0.000454	0.00293	CcSEcCtD
Silodosin—Breast disorder—Capecitabine—kidney cancer	0.000454	0.00293	CcSEcCtD
Silodosin—Skin disorder—Sorafenib—kidney cancer	0.000452	0.00291	CcSEcCtD
Silodosin—Headache—Temsirolimus—kidney cancer	0.000452	0.00291	CcSEcCtD
Silodosin—Nasopharyngitis—Capecitabine—kidney cancer	0.00045	0.0029	CcSEcCtD
Silodosin—Dizziness—Pazopanib—kidney cancer	0.000449	0.0029	CcSEcCtD
Silodosin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000447	0.00288	CcSEcCtD
Silodosin—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000447	0.00288	CcSEcCtD
Silodosin—Sinusitis—Paclitaxel—kidney cancer	0.000443	0.00285	CcSEcCtD
Silodosin—Shock—Sunitinib—kidney cancer	0.000441	0.00284	CcSEcCtD
Silodosin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000441	0.00284	CcSEcCtD
Silodosin—Nervous system disorder—Sunitinib—kidney cancer	0.00044	0.00283	CcSEcCtD
Silodosin—Gastrointestinal pain—Everolimus—kidney cancer	0.000439	0.00283	CcSEcCtD
Silodosin—Skin disorder—Sunitinib—kidney cancer	0.000435	0.0028	CcSEcCtD
Silodosin—Rash—Pazopanib—kidney cancer	0.000429	0.00276	CcSEcCtD
Silodosin—Nausea—Temsirolimus—kidney cancer	0.000429	0.00276	CcSEcCtD
Silodosin—Dermatitis—Pazopanib—kidney cancer	0.000428	0.00276	CcSEcCtD
Silodosin—Abdominal pain—Vinblastine—kidney cancer	0.000426	0.00274	CcSEcCtD
Silodosin—Headache—Pazopanib—kidney cancer	0.000426	0.00274	CcSEcCtD
Silodosin—Abdominal pain—Everolimus—kidney cancer	0.000424	0.00273	CcSEcCtD
Silodosin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000423	0.00273	CcSEcCtD
Silodosin—Abdominal pain—Erlotinib—kidney cancer	0.000409	0.00264	CcSEcCtD
Silodosin—Insomnia—Sunitinib—kidney cancer	0.000405	0.00261	CcSEcCtD
Silodosin—Nausea—Pazopanib—kidney cancer	0.000404	0.0026	CcSEcCtD
Silodosin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000402	0.00259	CcSEcCtD
Silodosin—Cardiac disorder—Paclitaxel—kidney cancer	0.000393	0.00253	CcSEcCtD
Silodosin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000387	0.00249	CcSEcCtD
Silodosin—Asthenia—Vinblastine—kidney cancer	0.000387	0.00249	CcSEcCtD
Silodosin—Asthenia—Everolimus—kidney cancer	0.000385	0.00248	CcSEcCtD
Silodosin—Angiopathy—Paclitaxel—kidney cancer	0.000385	0.00248	CcSEcCtD
Silodosin—Immune system disorder—Paclitaxel—kidney cancer	0.000383	0.00247	CcSEcCtD
Silodosin—Mediastinal disorder—Paclitaxel—kidney cancer	0.000382	0.00246	CcSEcCtD
Silodosin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000381	0.00245	CcSEcCtD
Silodosin—Pruritus—Everolimus—kidney cancer	0.00038	0.00245	CcSEcCtD
Silodosin—Jaundice—Capecitabine—kidney cancer	0.000378	0.00243	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000373	0.0024	CcSEcCtD
Silodosin—Nervous system disorder—Vincristine—kidney cancer	0.000372	0.0024	CcSEcCtD
Silodosin—Asthenia—Erlotinib—kidney cancer	0.000372	0.00239	CcSEcCtD
Silodosin—Mental disorder—Paclitaxel—kidney cancer	0.000371	0.00239	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000371	0.00239	CcSEcCtD
Silodosin—Urticaria—Sorafenib—kidney cancer	0.00037	0.00238	CcSEcCtD
Silodosin—Diarrhoea—Vinblastine—kidney cancer	0.000369	0.00237	CcSEcCtD
Silodosin—Abdominal pain—Sorafenib—kidney cancer	0.000368	0.00237	CcSEcCtD
Silodosin—Diarrhoea—Everolimus—kidney cancer	0.000367	0.00237	CcSEcCtD
Silodosin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000367	0.00236	CcSEcCtD
Silodosin—Hepatobiliary disease—Capecitabine—kidney cancer	0.000366	0.00236	CcSEcCtD
Silodosin—Pruritus—Erlotinib—kidney cancer	0.000366	0.00236	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—kidney cancer	0.000362	0.00233	CcSEcCtD
Silodosin—Dizziness—Vinblastine—kidney cancer	0.000356	0.00229	CcSEcCtD
Silodosin—Dizziness—Everolimus—kidney cancer	0.000355	0.00229	CcSEcCtD
Silodosin—Abdominal pain—Sunitinib—kidney cancer	0.000354	0.00228	CcSEcCtD
Silodosin—Diarrhoea—Erlotinib—kidney cancer	0.000354	0.00228	CcSEcCtD
Silodosin—Hypotension—Vincristine—kidney cancer	0.000354	0.00228	CcSEcCtD
Silodosin—Nervous system disorder—Gemcitabine—kidney cancer	0.000353	0.00227	CcSEcCtD
Silodosin—Skin disorder—Gemcitabine—kidney cancer	0.000349	0.00225	CcSEcCtD
Silodosin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000347	0.00224	CcSEcCtD
Silodosin—Insomnia—Vincristine—kidney cancer	0.000343	0.00221	CcSEcCtD
Silodosin—Dizziness—Erlotinib—kidney cancer	0.000342	0.00221	CcSEcCtD
Silodosin—Rash—Everolimus—kidney cancer	0.000338	0.00218	CcSEcCtD
Silodosin—Dermatitis—Everolimus—kidney cancer	0.000338	0.00218	CcSEcCtD
Silodosin—Headache—Vinblastine—kidney cancer	0.000337	0.00217	CcSEcCtD
Silodosin—Purpura—Doxorubicin—kidney cancer	0.000336	0.00217	CcSEcCtD
Silodosin—Headache—Everolimus—kidney cancer	0.000336	0.00217	CcSEcCtD
Silodosin—Hypotension—Gemcitabine—kidney cancer	0.000336	0.00216	CcSEcCtD
Silodosin—Abdominal pain—Dactinomycin—kidney cancer	0.000335	0.00216	CcSEcCtD
Silodosin—Asthenia—Sorafenib—kidney cancer	0.000334	0.00215	CcSEcCtD
Silodosin—Syncope—Paclitaxel—kidney cancer	0.000331	0.00213	CcSEcCtD
Silodosin—Pruritus—Sorafenib—kidney cancer	0.00033	0.00212	CcSEcCtD
Silodosin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000327	0.00211	CcSEcCtD
Silodosin—Rash—Erlotinib—kidney cancer	0.000326	0.0021	CcSEcCtD
Silodosin—Dermatitis—Erlotinib—kidney cancer	0.000326	0.0021	CcSEcCtD
Silodosin—Palpitations—Paclitaxel—kidney cancer	0.000326	0.0021	CcSEcCtD
Silodosin—Insomnia—Gemcitabine—kidney cancer	0.000325	0.0021	CcSEcCtD
Silodosin—Headache—Erlotinib—kidney cancer	0.000324	0.00209	CcSEcCtD
Silodosin—Loss of consciousness—Paclitaxel—kidney cancer	0.000324	0.00209	CcSEcCtD
Silodosin—Cardiac disorder—Capecitabine—kidney cancer	0.000323	0.00208	CcSEcCtD
Silodosin—Asthenia—Sunitinib—kidney cancer	0.000322	0.00207	CcSEcCtD
Silodosin—Nausea—Vinblastine—kidney cancer	0.00032	0.00206	CcSEcCtD
Silodosin—Nausea—Everolimus—kidney cancer	0.000319	0.00205	CcSEcCtD
Silodosin—Diarrhoea—Sorafenib—kidney cancer	0.000319	0.00205	CcSEcCtD
Silodosin—Pruritus—Sunitinib—kidney cancer	0.000317	0.00204	CcSEcCtD
Silodosin—Angiopathy—Capecitabine—kidney cancer	0.000316	0.00203	CcSEcCtD
Silodosin—Immune system disorder—Capecitabine—kidney cancer	0.000314	0.00202	CcSEcCtD
Silodosin—Mediastinal disorder—Capecitabine—kidney cancer	0.000313	0.00202	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000312	0.00201	CcSEcCtD
Silodosin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000311	0.002	CcSEcCtD
Silodosin—Gastrointestinal pain—Vincristine—kidney cancer	0.00031	0.002	CcSEcCtD
Silodosin—Dizziness—Sorafenib—kidney cancer	0.000308	0.00198	CcSEcCtD
Silodosin—Nausea—Erlotinib—kidney cancer	0.000308	0.00198	CcSEcCtD
Silodosin—Dry mouth—Paclitaxel—kidney cancer	0.000307	0.00198	CcSEcCtD
Silodosin—Diarrhoea—Sunitinib—kidney cancer	0.000307	0.00198	CcSEcCtD
Silodosin—Mental disorder—Capecitabine—kidney cancer	0.000305	0.00196	CcSEcCtD
Silodosin—Asthenia—Dactinomycin—kidney cancer	0.000304	0.00196	CcSEcCtD
Silodosin—Abdominal pain—Vincristine—kidney cancer	0.0003	0.00193	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000299	0.00193	CcSEcCtD
Silodosin—Dizziness—Sunitinib—kidney cancer	0.000296	0.00191	CcSEcCtD
Silodosin—Shock—Paclitaxel—kidney cancer	0.000296	0.00191	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000296	0.00191	CcSEcCtD
Silodosin—Nervous system disorder—Paclitaxel—kidney cancer	0.000295	0.0019	CcSEcCtD
Silodosin—Tachycardia—Paclitaxel—kidney cancer	0.000294	0.00189	CcSEcCtD
Silodosin—Rash—Sorafenib—kidney cancer	0.000294	0.00189	CcSEcCtD
Silodosin—Dermatitis—Sorafenib—kidney cancer	0.000293	0.00189	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—kidney cancer	0.000293	0.00189	CcSEcCtD
Silodosin—Skin disorder—Paclitaxel—kidney cancer	0.000292	0.00188	CcSEcCtD
Silodosin—Headache—Sorafenib—kidney cancer	0.000292	0.00188	CcSEcCtD
Silodosin—Diarrhoea—Dactinomycin—kidney cancer	0.00029	0.00187	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—kidney cancer	0.00029	0.00187	CcSEcCtD
Silodosin—Rash—Sunitinib—kidney cancer	0.000283	0.00182	CcSEcCtD
Silodosin—Dermatitis—Sunitinib—kidney cancer	0.000282	0.00182	CcSEcCtD
Silodosin—Hypotension—Paclitaxel—kidney cancer	0.000281	0.00181	CcSEcCtD
Silodosin—Headache—Sunitinib—kidney cancer	0.000281	0.00181	CcSEcCtD
Silodosin—Nausea—Sorafenib—kidney cancer	0.000277	0.00178	CcSEcCtD
Silodosin—Insomnia—Paclitaxel—kidney cancer	0.000272	0.00175	CcSEcCtD
Silodosin—Asthenia—Vincristine—kidney cancer	0.000272	0.00175	CcSEcCtD
Silodosin—Syncope—Capecitabine—kidney cancer	0.000272	0.00175	CcSEcCtD
Silodosin—Palpitations—Capecitabine—kidney cancer	0.000268	0.00172	CcSEcCtD
Silodosin—Rash—Dactinomycin—kidney cancer	0.000268	0.00172	CcSEcCtD
Silodosin—Nausea—Sunitinib—kidney cancer	0.000266	0.00172	CcSEcCtD
Silodosin—Loss of consciousness—Capecitabine—kidney cancer	0.000266	0.00171	CcSEcCtD
Silodosin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00026	0.00167	CcSEcCtD
Silodosin—Diarrhoea—Vincristine—kidney cancer	0.000259	0.00167	CcSEcCtD
Silodosin—Asthenia—Gemcitabine—kidney cancer	0.000258	0.00166	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000256	0.00165	CcSEcCtD
Silodosin—Pruritus—Gemcitabine—kidney cancer	0.000254	0.00164	CcSEcCtD
Silodosin—Dry mouth—Capecitabine—kidney cancer	0.000252	0.00162	CcSEcCtD
Silodosin—Nausea—Dactinomycin—kidney cancer	0.000252	0.00162	CcSEcCtD
Silodosin—Dizziness—Vincristine—kidney cancer	0.000251	0.00162	CcSEcCtD
Silodosin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000246	0.00159	CcSEcCtD
Silodosin—Diarrhoea—Gemcitabine—kidney cancer	0.000246	0.00159	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—kidney cancer	0.000243	0.00157	CcSEcCtD
Silodosin—Shock—Capecitabine—kidney cancer	0.000243	0.00157	CcSEcCtD
Silodosin—Nervous system disorder—Capecitabine—kidney cancer	0.000242	0.00156	CcSEcCtD
Silodosin—Tachycardia—Capecitabine—kidney cancer	0.000241	0.00155	CcSEcCtD
Silodosin—Skin disorder—Capecitabine—kidney cancer	0.00024	0.00155	CcSEcCtD
Silodosin—Urticaria—Paclitaxel—kidney cancer	0.000239	0.00154	CcSEcCtD
Silodosin—Rash—Vincristine—kidney cancer	0.000239	0.00154	CcSEcCtD
Silodosin—Dermatitis—Vincristine—kidney cancer	0.000239	0.00154	CcSEcCtD
Silodosin—Abdominal pain—Paclitaxel—kidney cancer	0.000238	0.00153	CcSEcCtD
Silodosin—Headache—Vincristine—kidney cancer	0.000238	0.00153	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000236	0.00152	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—kidney cancer	0.000234	0.00151	CcSEcCtD
Silodosin—Hypotension—Capecitabine—kidney cancer	0.000231	0.00149	CcSEcCtD
Silodosin—Rash—Gemcitabine—kidney cancer	0.000227	0.00146	CcSEcCtD
Silodosin—Dermatitis—Gemcitabine—kidney cancer	0.000227	0.00146	CcSEcCtD
Silodosin—Headache—Gemcitabine—kidney cancer	0.000225	0.00145	CcSEcCtD
Silodosin—Nausea—Vincristine—kidney cancer	0.000225	0.00145	CcSEcCtD
Silodosin—Insomnia—Capecitabine—kidney cancer	0.000224	0.00144	CcSEcCtD
Silodosin—Asthenia—Paclitaxel—kidney cancer	0.000216	0.00139	CcSEcCtD
Silodosin—Nausea—Gemcitabine—kidney cancer	0.000214	0.00138	CcSEcCtD
Silodosin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000213	0.00137	CcSEcCtD
Silodosin—Pruritus—Paclitaxel—kidney cancer	0.000213	0.00137	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—kidney cancer	0.000208	0.00134	CcSEcCtD
Silodosin—Diarrhoea—Paclitaxel—kidney cancer	0.000206	0.00133	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—kidney cancer	0.000203	0.00131	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—kidney cancer	0.000203	0.0013	CcSEcCtD
Silodosin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000202	0.0013	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000202	0.0013	CcSEcCtD
Silodosin—Dizziness—Paclitaxel—kidney cancer	0.000199	0.00128	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—kidney cancer	0.000196	0.00127	CcSEcCtD
Silodosin—Urticaria—Capecitabine—kidney cancer	0.000196	0.00126	CcSEcCtD
Silodosin—Abdominal pain—Capecitabine—kidney cancer	0.000195	0.00126	CcSEcCtD
Silodosin—Rash—Paclitaxel—kidney cancer	0.00019	0.00122	CcSEcCtD
Silodosin—Dermatitis—Paclitaxel—kidney cancer	0.00019	0.00122	CcSEcCtD
Silodosin—Headache—Paclitaxel—kidney cancer	0.000189	0.00122	CcSEcCtD
Silodosin—Nausea—Paclitaxel—kidney cancer	0.000179	0.00115	CcSEcCtD
Silodosin—Asthenia—Capecitabine—kidney cancer	0.000177	0.00114	CcSEcCtD
Silodosin—Syncope—Doxorubicin—kidney cancer	0.000175	0.00113	CcSEcCtD
Silodosin—Pruritus—Capecitabine—kidney cancer	0.000175	0.00113	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—kidney cancer	0.000172	0.00111	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—kidney cancer	0.000172	0.00111	CcSEcCtD
Silodosin—Diarrhoea—Capecitabine—kidney cancer	0.000169	0.00109	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000165	0.00106	CcSEcCtD
Silodosin—Dizziness—Capecitabine—kidney cancer	0.000163	0.00105	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—kidney cancer	0.000163	0.00105	CcSEcCtD
Silodosin—Shock—Doxorubicin—kidney cancer	0.000157	0.00101	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—kidney cancer	0.000156	0.00101	CcSEcCtD
Silodosin—Rash—Capecitabine—kidney cancer	0.000156	0.001	CcSEcCtD
Silodosin—Dermatitis—Capecitabine—kidney cancer	0.000156	0.001	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—kidney cancer	0.000155	0.001	CcSEcCtD
Silodosin—Headache—Capecitabine—kidney cancer	0.000155	0.000997	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—kidney cancer	0.000155	0.000997	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—kidney cancer	0.000149	0.000959	CcSEcCtD
Silodosin—Nausea—Capecitabine—kidney cancer	0.000147	0.000946	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—kidney cancer	0.000144	0.000928	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000138	0.000886	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00013	0.000839	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—kidney cancer	0.000127	0.000815	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—kidney cancer	0.000126	0.000811	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—kidney cancer	0.000114	0.000736	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—kidney cancer	0.000113	0.000726	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—kidney cancer	0.000109	0.000702	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—kidney cancer	0.000105	0.000679	CcSEcCtD
Silodosin—Rash—Doxorubicin—kidney cancer	0.0001	0.000647	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—kidney cancer	0.0001	0.000646	CcSEcCtD
Silodosin—Headache—Doxorubicin—kidney cancer	9.98e-05	0.000643	CcSEcCtD
Silodosin—Nausea—Doxorubicin—kidney cancer	9.46e-05	0.00061	CcSEcCtD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.48e-05	0.000576	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—PIK3CA—kidney cancer	2.45e-05	0.000568	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GRB7—kidney cancer	2.41e-05	0.000559	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SFRP2—kidney cancer	2.41e-05	0.000559	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.38e-05	0.000553	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.36e-05	0.000547	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ANXA1—kidney cancer	2.34e-05	0.000543	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—FH—kidney cancer	2.31e-05	0.000537	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APRT—kidney cancer	2.31e-05	0.000537	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.31e-05	0.000536	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.28e-05	0.00053	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.24e-05	0.00052	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ITPR2—kidney cancer	2.24e-05	0.000519	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—POMC—kidney cancer	2.24e-05	0.000519	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.23e-05	0.000518	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACY1—kidney cancer	2.21e-05	0.000513	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.19e-05	0.000508	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP2—kidney cancer	2.19e-05	0.000507	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKAP13—kidney cancer	2.19e-05	0.000507	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPC3—kidney cancer	2.18e-05	0.000505	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—PIK3CA—kidney cancer	2.18e-05	0.000505	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTP1—kidney cancer	2.15e-05	0.000499	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.13e-05	0.000493	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.12e-05	0.000491	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA2—kidney cancer	2.12e-05	0.000491	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.12e-05	0.000491	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALAD—kidney cancer	2.06e-05	0.000479	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.05e-05	0.000476	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ABCB1—kidney cancer	2.04e-05	0.000472	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNA1—kidney cancer	2.03e-05	0.000471	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EIF4EBP1—kidney cancer	2.02e-05	0.000468	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HSPB1—kidney cancer	2.02e-05	0.000468	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.02e-05	0.000468	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.01e-05	0.000467	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.01e-05	0.000467	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GRB7—kidney cancer	2e-05	0.000464	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2e-05	0.000464	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PIK3CA—kidney cancer	1.99e-05	0.000461	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTM1—kidney cancer	1.98e-05	0.000458	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.97e-05	0.000457	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.95e-05	0.000452	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.95e-05	0.000451	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP2—kidney cancer	1.94e-05	0.00045	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKAP13—kidney cancer	1.94e-05	0.00045	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PGK1—kidney cancer	1.89e-05	0.000438	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC5A3—kidney cancer	1.89e-05	0.000438	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PDHB—kidney cancer	1.88e-05	0.000437	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PSMD7—kidney cancer	1.88e-05	0.000435	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TSC1—kidney cancer	1.88e-05	0.000435	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ANXA1—kidney cancer	1.88e-05	0.000435	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.88e-05	0.000435	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1A1—kidney cancer	1.87e-05	0.000435	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ITPR2—kidney cancer	1.86e-05	0.000431	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LDHB—kidney cancer	1.85e-05	0.000429	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FLT1—kidney cancer	1.82e-05	0.000422	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GRB7—kidney cancer	1.78e-05	0.000412	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.77e-05	0.00041	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.76e-05	0.000408	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—POMC—kidney cancer	1.71e-05	0.000398	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNA1—kidney cancer	1.68e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUNB—kidney cancer	1.68e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PAK1—kidney cancer	1.68e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EIF4EBP1—kidney cancer	1.68e-05	0.000389	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HSPB1—kidney cancer	1.68e-05	0.000389	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.66e-05	0.000386	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ITPR2—kidney cancer	1.65e-05	0.000383	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.62e-05	0.000375	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA9—kidney cancer	1.6e-05	0.000372	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.58e-05	0.000367	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSMD7—kidney cancer	1.56e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TSC1—kidney cancer	1.56e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ANXA1—kidney cancer	1.56e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—POMC—kidney cancer	1.56e-05	0.000361	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000356	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPAT—kidney cancer	1.53e-05	0.000356	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FLT1—kidney cancer	1.51e-05	0.00035	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	1.5e-05	0.000347	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.5e-05	0.000347	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	1.49e-05	0.000345	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	1.49e-05	0.000345	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APRT—kidney cancer	1.43e-05	0.000331	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FH—kidney cancer	1.43e-05	0.000331	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—POMC—kidney cancer	1.42e-05	0.00033	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUNB—kidney cancer	1.4e-05	0.000324	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PAK1—kidney cancer	1.4e-05	0.000324	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—POMC—kidney cancer	1.4e-05	0.000324	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	1.38e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TSC1—kidney cancer	1.38e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	1.38e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF2—kidney cancer	1.38e-05	0.000319	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.37e-05	0.000319	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN2B—kidney cancer	1.37e-05	0.000318	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CRABP1—kidney cancer	1.36e-05	0.000316	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPC3—kidney cancer	1.34e-05	0.000311	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FLT1—kidney cancer	1.34e-05	0.000311	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1R—kidney cancer	1.33e-05	0.000309	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.33e-05	0.000308	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA2—kidney cancer	1.3e-05	0.000303	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—POMC—kidney cancer	1.29e-05	0.0003	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RAF1—kidney cancer	1.28e-05	0.000298	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALAD—kidney cancer	1.27e-05	0.000295	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ITPR2—kidney cancer	1.27e-05	0.000294	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—IL2—kidney cancer	1.27e-05	0.000294	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	1.26e-05	0.000293	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PAK1—kidney cancer	1.24e-05	0.000288	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUNB—kidney cancer	1.24e-05	0.000288	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000288	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000281	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PGK1—kidney cancer	1.16e-05	0.00027	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.00027	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTT1—kidney cancer	1.16e-05	0.000268	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ACHE—kidney cancer	1.16e-05	0.000268	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL2—kidney cancer	1.15e-05	0.000267	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—POMC—kidney cancer	1.15e-05	0.000266	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF2—kidney cancer	1.14e-05	0.000265	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LDHB—kidney cancer	1.14e-05	0.000264	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN2B—kidney cancer	1.14e-05	0.000264	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000258	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1R—kidney cancer	1.11e-05	0.000256	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HIF1A—kidney cancer	1.1e-05	0.000254	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SCARB1—kidney cancer	1.09e-05	0.000254	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TSC2—kidney cancer	1.09e-05	0.000254	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS1—kidney cancer	1.08e-05	0.000251	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RAF1—kidney cancer	1.06e-05	0.000247	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000247	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—IL2—kidney cancer	1.05e-05	0.000244	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—kidney cancer	1.05e-05	0.000243	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF2—kidney cancer	1.02e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	1.01e-05	0.000234	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BCHE—kidney cancer	1.01e-05	0.000234	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC5A5—kidney cancer	9.95e-06	0.000231	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA9—kidney cancer	9.89e-06	0.000229	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	9.82e-06	0.000228	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTEN—kidney cancer	9.72e-06	0.000225	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APC—kidney cancer	9.66e-06	0.000224	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KIT—kidney cancer	9.66e-06	0.000224	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A1—kidney cancer	9.61e-06	0.000223	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL2—kidney cancer	9.55e-06	0.000221	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	9.46e-06	0.000219	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	9.34e-06	0.000217	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK3—kidney cancer	9.25e-06	0.000215	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—POMC—kidney cancer	9.19e-06	0.000213	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.17e-06	0.000213	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	9.1e-06	0.000211	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BRAF—kidney cancer	9.08e-06	0.000211	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TSC2—kidney cancer	9.08e-06	0.000211	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK1—kidney cancer	8.8e-06	0.000204	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—kidney cancer	8.7e-06	0.000202	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL2—kidney cancer	8.48e-06	0.000197	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—kidney cancer	8.41e-06	0.000195	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CRABP1—kidney cancer	8.41e-06	0.000195	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—KRAS—kidney cancer	8.31e-06	0.000193	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	8.08e-06	0.000187	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TSC2—kidney cancer	8.06e-06	0.000187	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—kidney cancer	8.02e-06	0.000186	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APC—kidney cancer	8.02e-06	0.000186	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KIT—kidney cancer	8.02e-06	0.000186	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ITPR2—kidney cancer	7.81e-06	0.000181	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—kidney cancer	7.73e-06	0.000179	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	7.68e-06	0.000178	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—kidney cancer	7.64e-06	0.000177	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—kidney cancer	7.63e-06	0.000177	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAF1—kidney cancer	7.58e-06	0.000176	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RELA—kidney cancer	7.55e-06	0.000175	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BRAF—kidney cancer	7.53e-06	0.000175	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB2—kidney cancer	7.5e-06	0.000174	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MTOR—kidney cancer	7.4e-06	0.000172	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—kidney cancer	7.37e-06	0.000171	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	7.3e-06	0.000169	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACHE—kidney cancer	7.13e-06	0.000165	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—kidney cancer	7.13e-06	0.000165	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KIT—kidney cancer	7.12e-06	0.000165	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APC—kidney cancer	7.12e-06	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A1—kidney cancer	6.98e-06	0.000162	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	6.98e-06	0.000162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	6.94e-06	0.000161	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	6.9e-06	0.00016	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—kidney cancer	6.86e-06	0.000159	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	6.82e-06	0.000158	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL2—kidney cancer	6.8e-06	0.000158	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—kidney cancer	6.78e-06	0.000157	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SCARB1—kidney cancer	6.75e-06	0.000156	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BRAF—kidney cancer	6.69e-06	0.000155	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS1—kidney cancer	6.68e-06	0.000155	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—kidney cancer	6.62e-06	0.000154	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUN—kidney cancer	6.61e-06	0.000153	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	6.56e-06	0.000152	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMD7—kidney cancer	6.55e-06	0.000152	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	6.49e-06	0.00015	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTEN—kidney cancer	6.39e-06	0.000148	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	6.34e-06	0.000147	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAF1—kidney cancer	6.29e-06	0.000146	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RELA—kidney cancer	6.26e-06	0.000145	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	6.22e-06	0.000144	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BCHE—kidney cancer	6.21e-06	0.000144	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	6.2e-06	0.000144	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MTOR—kidney cancer	6.14e-06	0.000142	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.13e-06	0.000142	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	6.13e-06	0.000142	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.92e-06	0.000137	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	5.78e-06	0.000134	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	5.76e-06	0.000134	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL2—kidney cancer	5.64e-06	0.000131	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	5.63e-06	0.000131	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAF1—kidney cancer	5.59e-06	0.00013	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RELA—kidney cancer	5.56e-06	0.000129	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	5.53e-06	0.000128	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—kidney cancer	5.5e-06	0.000128	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUN—kidney cancer	5.49e-06	0.000127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	5.46e-06	0.000127	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MTOR—kidney cancer	5.46e-06	0.000127	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	5.45e-06	0.000126	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—kidney cancer	5.31e-06	0.000123	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTEN—kidney cancer	5.31e-06	0.000123	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—POMC—kidney cancer	5.21e-06	0.000121	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	5.2e-06	0.000121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	5.12e-06	0.000119	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL2—kidney cancer	5.01e-06	0.000116	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—kidney cancer	4.94e-06	0.000115	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KRAS—kidney cancer	4.91e-06	0.000114	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—kidney cancer	4.88e-06	0.000113	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUN—kidney cancer	4.87e-06	0.000113	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	4.84e-06	0.000112	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	4.79e-06	0.000111	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTEN—kidney cancer	4.71e-06	0.000109	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCB1—kidney cancer	4.68e-06	0.000108	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—kidney cancer	4.54e-06	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	4.53e-06	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	4.51e-06	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—kidney cancer	4.41e-06	0.000102	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—kidney cancer	4.36e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	4.31e-06	0.0001	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.3e-06	9.98e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	4.26e-06	9.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—kidney cancer	4.15e-06	9.63e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KRAS—kidney cancer	4.08e-06	9.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	4.03e-06	9.34e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.92e-06	9.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	3.83e-06	8.89e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	3.74e-06	8.69e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTEN—kidney cancer	3.62e-06	8.4e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—kidney cancer	3.62e-06	8.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KRAS—kidney cancer	3.62e-06	8.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	3.33e-06	7.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—kidney cancer	3.22e-06	7.46e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—kidney cancer	3.21e-06	7.44e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—kidney cancer	2.56e-06	5.94e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—kidney cancer	2.56e-06	5.93e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTEN—kidney cancer	2.23e-06	5.18e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.57e-06	3.65e-05	CbGpPWpGaD
